2013
Brain Human Monoclonal Autoantibody from Sydenham Chorea Targets Dopaminergic Neurons in Transgenic Mice and Signals Dopamine D2 Receptor: Implications in Human Disease
Cox CJ, Sharma M, Leckman JF, Zuccolo J, Zuccolo A, Kovoor A, Swedo SE, Cunningham MW. Brain Human Monoclonal Autoantibody from Sydenham Chorea Targets Dopaminergic Neurons in Transgenic Mice and Signals Dopamine D2 Receptor: Implications in Human Disease. The Journal Of Immunology 2013, 191: 5524-5541. PMID: 24184556, PMCID: PMC3848617, DOI: 10.4049/jimmunol.1102592.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsAntigens, BacterialAutoantibodiesBasal GangliaChildChoreaCross ReactionsDopamineDopaminergic NeuronsG(M1) GangliosideHEK293 CellsHumansImmunoglobulin GMiceMice, Inbred C57BLMice, TransgenicReceptors, Dopamine D2Recombinant Fusion ProteinsRheumatic FeverSignal TransductionStreptococcal InfectionsTransgenesConceptsSydenham's choreaDopamine D2 receptorsDopaminergic neuronsD2 receptorsTransgenic micePediatric autoimmune neuropsychiatric disordersDose-dependent inhibitoryMain neurologic manifestationsAutoimmune neuropsychiatric disordersBehavioral disordersHuman monoclonal autoantibodiesBrain AgsNeurologic manifestationsRheumatic feverChoreiform movementsTg miceBasal gangliaHuman dopamine D2 receptorAb reactivityTyrosine hydroxylaseAutoantibodiesB cellsMonoclonal autoantibodiesNeuropsychiatric disordersD2R
2010
Neurobiological Substrates of Tourette's Disorder
Leckman JF, Bloch MH, Smith ME, Larabi D, Hampson M. Neurobiological Substrates of Tourette's Disorder. Journal Of Child And Adolescent Psychopharmacology 2010, 20: 237-247. PMID: 20807062, PMCID: PMC2958453, DOI: 10.1089/cap.2009.0118.Chapters
2007
Frontal dopaminergic abnormality in Tourette syndrome: A postmortem analysis
Yoon DY, Gause CD, Leckman JF, Singer HS. Frontal dopaminergic abnormality in Tourette syndrome: A postmortem analysis. Journal Of The Neurological Sciences 2007, 255: 50-56. PMID: 17337006, DOI: 10.1016/j.jns.2007.01.069.Peer-Reviewed Original ResearchConceptsTourette syndromeDopamine transporterReceptor densityPathophysiology of TSAlpha-adrenergic receptorsSex-matched controlsD2 receptor densityPostmortem brain tissueFrontal regionsDopaminergic dysfunctionNeurochemical abnormalitiesDopaminergic abnormalitiesNeurochemical markersTS patientsFrontal cortexSemiquantitative immunoblottingFrontal lobeBrain tissueTS subjectsTerminal markersOccipital regionAbnormalitiesVesicular dockingPathophysiologySyndrome
2002
Maternal behavior and developmental psychopathology
Leckman JF, Herman AE. Maternal behavior and developmental psychopathology. Biological Psychiatry 2002, 51: 27-43. PMID: 11801229, DOI: 10.1016/s0006-3223(01)01277-x.Peer-Reviewed Original ResearchConceptsMaternal behaviorNeuronal nitric oxide synthaseEstrogen alpha receptorsNitric oxide synthaseMouse strain backgroundDopamine beta hydroxylaseGene knockout dataAnimal model systemsGene knockout studiesGene knockout technologyPeer-reviewed journalsOxide synthaseAlpha receptorsBehavioral deficitsSearch of literatureBeta hydroxylaseDisease pathogenesisTranscription factorsMolecular basisGenetic factorsKnockout studiesSpecific genesKnockout dataKnockout technologyStrain background
1995
[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder
Malison RT, McDougle CJ, van Dyck CH, Scahill L, Baldwin RM, Seibyl JP, Price LH, Leckman JF, Innis RB. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. American Journal Of Psychiatry 1995, 152: 1359-1361. PMID: 7653693, DOI: 10.1176/ajp.152.9.1359.Peer-Reviewed Original ResearchConceptsTourette's disorderComparison subjectsDisorder patientsGender-matched healthy comparison subjectsStriatal dopamine transporter bindingStriatal dopamine transporter densityCIT SPECT imagingDopamine transporter levelsDopamine transporter densityDopamine transporter bindingPresynaptic dopamine functionTourette's disorder patientsPost-mortem findingsHealthy comparison subjectsSingle photon emissionBeta-carbomethoxy-3 betaAdult patientsCIT bindingPost-mortem resultsTransporter bindingDopamine functionTransporter densityTransporter levelsSPECT imagingDisorders
1990
Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?
Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? The Journal Of Clinical Psychiatry 1990, 51 Suppl: 36-43; discussion 55-8. PMID: 2199433.Peer-Reviewed Original Research
1987
Assessment of dopaminergic function in children and adults: long and brief debrisoquin administration combined with plasma homovanillic acid.
Riddle MA, Leckman JF, Anderson GM, Hardin MT, Ort SI, Towbin KE, Shaywitz BA, Cohen DJ. Assessment of dopaminergic function in children and adults: long and brief debrisoquin administration combined with plasma homovanillic acid. Psychopharmacology Bulletin 1987, 23: 411-4. PMID: 3481088.Peer-Reviewed Original Research
1986
Assessment or central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration
Riddle MA, Leckman JF, Cohen DJ, Anderson M, Ort SI, Caruso KA, Shaywitz BA. Assessment or central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration. Journal Of Neural Transmission 1986, 67: 31-43. PMID: 3465864, DOI: 10.1007/bf01243357.Peer-Reviewed Original ResearchConceptsCentral dopaminergic functionDopaminergic functionHomovanillic acidDopamine metabolite homovanillic acidCentral DA activityChronic oral administrationPlasma-free homovanillic acidSingle oral doseBlood-brain barrierMetabolite homovanillic acidBehavioral side effectsOral dosePeripheral metabolismDA activityOral administrationSide effectsDebrisoquinAdministration methodsMarked reductionHVAAdministrationPeripheral formationAdultsValid techniqueChildren
1983
Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research.
Leckman JF, Cohen DJ. Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research. Psychiatric Developments 1983, 1: 301-16. PMID: 6324164.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAge FactorsAttention Deficit Disorder with HyperactivityChildClonidineCompulsive BehaviorDopamineFemaleHaloperidolHomovanillic AcidHumansMaleObsessive BehaviorObsessive-Compulsive DisorderParasympathomimeticsPhysostigmineReceptors, AdrenergicSerotoninSex FactorsTic DisordersTourette SyndromeConceptsTourette syndromeGilles de la Tourette's syndromeDopamine receptor hypersensitivityLa Tourette's syndromeChronic multiple ticsWaning of symptomsComplex stereotypiesReceptor hypersensitivityNeurochemical disturbancesClinical presentationMetabolic findingsCSF HVAMotor involvementDopamine blockersTS patientsObsessive-compulsive behaviorClinical practiceMultiple ticsGilles deNatural historyRostrocaudal progressionFamilial aggregationSyndromeSymptomsDisorders
1982
Clonidine in the treatment of Tourette syndrome: a review of data.
Leckman JF, Cohen DJ, Detlor J, Young JG, Harcherik D, Shaywitz BA. Clonidine in the treatment of Tourette syndrome: a review of data. Advances In Neurology 1982, 35: 391-401. PMID: 6756089.Peer-Reviewed Original ResearchConceptsTS patientsLong-term symptomatic improvementPathophysiology of TSDouble-blind trialEfficacy of clonidineMinority of patientsGrowth hormone releasePrimary pathogenic importanceMinimal side effectsSymptomatic improvementBlood pressureProfile of responseNoradrenergic mechanismsMHPG levelsTherapeutic responseHormone releaseClonidinePathogenic importanceAcute dosesSide effectsTourette syndromeBehavioral symptomsPharmacologic investigationsNeurochemical systemsPatients